drugset / Trial / NCT00955552

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee

NCT00955552

Phase 3 Completed 100 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of glucosamine and chondroitin sulfate association in the treatment of patients with osteoarthrosis of the knee.

Timeline

Start
2010-08
Primary completion
2011-02
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin Unknown 400 mg Oral
Subject Glucosamine Small molecule 500 mg Oral

Indications